Anti-Retrovirals for Kaposi's Sarcoma (ARKS)

This study has been completed.
Sponsor:
Collaborators:
Gilead Sciences
Abbott
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00444379
First received: March 6, 2007
Last updated: August 19, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)